Long

Trevena in for a bull run.

Aktualisiert
Waiting for the NDA resubmission news. Expecting the company presentation in 2020 BIO CEO & Investor Conference on Feb 11, 2020, to cause the market to move upward.
In a possible future FDA approval for their IV oliceridine drug will cause a nice Trend up. Holding all Longs and Share positions.
Trade ist aktiv
Snapshot

Support zone tested and retraced, still showing bullish signs.
Anmerkung
Snapshot

Bullshit Flag next Target is 1.95
Trend Analysis

Haftungsausschluss